Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A narrative review from a multispecialty task force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)

Critical Care Medicine

Volumn 45, Issue 12, 2017, Pages 2089-2098

  Annane, Djillali ^a   Pastores, Stephen M ^b   Arlt, Wiebke ^c   Balk, Robert A ^d   Beishuizen, Albertus ^e   Briegel, Josef ^f   Carcillo, Joseph ^g   Christ Crain, Mirjam ^h   Cooper, Mark S ⁱ   Marik, Paul E ^j   Meduri, Gianfranco Umberto ^k   Olsen, Keith M ^l   Rochwerg, Bram ^m   Rodgers, Sophia C ⁿ   Russell, James A ^o   Van Den Berghe, Greet ^p  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e MEDISCH SPECTRUM TWENTE   (Netherlands)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^m MCMASTER UNIVERSITY   (Canada)

ⁿ UNIVERSITY OF NEW MEXICO   (United States)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

more..

Author keywords

Corticosteroid insufficiency; Critical illness; Glucocorticoid receptor; Glucocorticoids; Sepsis

Indexed keywords

CYTOKINE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADVISORY COMMITTEE; CRITICAL ILLNESS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTENSIVE CARE; METABOLISM; NEUROSECRETORY CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADRENAL INSUFFICIENCY; ADVISORY COMMITTEES; CRITICAL CARE; CRITICAL ILLNESS; CYTOKINES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROENDOCRINE CELLS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 85039871681     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002724     Document Type: Article

References (85)

1. Marik PE, Pastores SM, Annane D, et al: American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36(6):1937-1949
2. Nicolaides NC, Kyratzi E, Lamprokostopoulou A, et al: Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 2015; 22:6-19
3. Meduri GU, Annane D, Chrousos GP, et al: Activation and regulation of systemic inflammation in ARDS: Rationale for prolonged glucocorticoid therapy. Chest 2009; 136:1631-1643
4. Elenkov IJ, Iezzoni DG, Daly A, et al: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12:255-269
5. Suffredini AF, Fantuzzi G, Badolato R, et al: New insights into the biology of the acute phase response. J Clin Immunol 1999; 19:203-214
6. Friedman R, Hughes AL: Molecular evolution of the NF-kappaB signaling system. Immunogenetics 2002; 53(10-11):964-974
7. Meduri GU, Muthiah MP, Carratu P, et al: Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321-338
8. Lee SR, Kim HK, Song IS, et al: Glucocorticoids and their receptors: Insights into specific roles in mitochondria. Prog Biophys Mol Biol 2013; 112(1-2):44-54
9. Galon J, Franchimont D, Hiroi N, et al: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16:61-71
10. Li-Tempel T, Larra MF, Sandt E, et al: The cardiovascular and hypothalamus-pituitary-adrenal axis response to stress is controlled by glucocorticoid receptor sequence variants and promoter methylation. Clin Epigenetics 2016; 8:12
11. Midzak A, Papadopoulos V: Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies. Front Endocrinol (Lausanne) 2016; 7:106
12. Esteban NV, Loughlin T, Yergey AL, et al: Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72:39-45
13. Vassiliadi DA, Dimopoulou I, Tzanela M, et al: Longitudinal assessment of adrenal function in the early and prolonged phases of critical illness in septic patients: Relations to cytokine levels and outcome. J Clin Endocrinol Metab 2014; 99:4471-4480
14. Boonen E, Vervenne H, Meersseman P, et al: Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368:1477-1488
15. Boonen E, Meersseman P, Vervenne H, et al: Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab 2014; 306:E883-E892
16. Nenke MA, Rankin W, Chapman MJ, et al: Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications. Clin Endocrinol (Oxf) 2015; 82:801-807
17. Beishuizen A, Thijs LG, Vermes I: Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001; 27:1584-1591
18. Tomlinson JW, Moore J, Cooper MS, et al: Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: Tissuespecific induction by cytokines. Endocrinology 2001; 142:1982-1989
19. Cai TQ, Wong B, Mundt SS, et al: Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Biochem Mol Biol 2001; 77:117-122
20. Hapgood JP, Avenant C, Moliki JM: Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy. Pharmacol Ther 2016; 165:93-113
21. Charmandari E, Nicolaides NC, Chrousos GP: Adrenal insufficiency. Lancet 2014; 383:2152-2167
22. Cain DW, Cidlowski JA: Immune regulation by glucocorticoids. Nat Rev Immunol 2017; 17:233-247
23. Goodwin JE, Feng Y, Velazquez H, et al: Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A 2013; 110:306-311
24. Goodwin JE, Feng Y, Velazquez H, et al: Loss of the endothelial glucocorticoid receptor prevents the therapeutic protection afforded by dexamethasone after LPS. PLoS One 2014; 9:e108126
25. Peeters RP, Hagendorf A, Vanhorebeek I, et al: Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Clin Endocrinol (Oxf) 2009; 71:145-153
26. Oakley RH, Cidlowski JA: The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 2013; 132:1033-1044
27. Boonen E, Bornstein SR, Van den Berghe G: New insights into the controversy of adrenal function during critical illness. Lancet Diabetes Endocrinol 2015; 3:805-815
28. Le Tulzo Y, Pangault C, Amiot L, et al: Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 2004; 169:1144-1151
29. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A doubleblind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
30. Arnalich F, Garcia-Palomero E, López J, et al: Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68:1942-1945
31. Lee YL, Chen W, Chen LY, et al: Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe communityacquired pneumonia. J Crit Care 2010; 25:176.e7-176.13
32. Gomez HG, Gonzalez SM, Londoño JM, et al: Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: A longitudinal study. Crit Care Med 2014; 42:771-780
33. Fernandez-Botran R, Uriarte SM, Arnold FW, et al: Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia. Inflammation 2014; 37:1158-1166
34. Kellum JA, Kong L, Fink MP, et al; GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007; 167:1655-1663
35. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
36. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108(5):1303-1314
37. Xiao W, Mindrinos MN, Seok J, et al; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 2011; 208:2581-2590
38. Aisiku IP, Yamal JM, Doshi P, et al: Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care 2016; 20:288
39. Yende S, D'Angelo G, Kellum JA, et al; GenIMS Investigators: Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177:1242-1247
40. Dunn AJ: Cytokine activation of the HPA axis. Ann N Y Acad Sci 2000; 917:608-617
41. Besedovsky H, del Rey A, Sorkin E, et al: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233:652-654
42. Kanczkowski W, Sue M, Zacharowski K, et al: The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis. Mol Cell Endocrinol 2015; 408:241-248
43. Darling G, Goldstein DS, Stull R, et al: Tumor necrosis factor: Immune endocrine interaction. Surgery 1989; 106:1155-1160
44. Mikhaylova IV, Kuulasmaa T, Jääskeläinen J, et al: Tumor necrosis factoralpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R. Endocrinology 2007; 148:386-392
45. Jäättelä M, Carpén O, Stenman UH, et al: Regulation of ACTHinduced steroidogenesis in human fetal adrenals by rTNF-alpha. Mol Cell Endocrinol 1990; 68:R31-R36
46. Jäättelä M, Ilvesmäki V, Voutilainen R, et al: Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991; 128:623-629
47. Engström L, Rosén K, Angel A, et al: Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland. Endocrinology 2008; 149:1436-1450
48. Bornstein SR, Zacharowski P, Schumann RR, et al: Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci U S A 2004; 101:16695-16700
49. Kanczkowski W, Alexaki VI, Tran N, et al: Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation. Proc Natl Acad Sci U S A 2013; 110:14801-14806
50. Jung B, Nougaret S, Chanques G, et al: The absence of adrenal gland enlargement during septic shock predicts mortality: A computed tomography study of 239 patients. Anesthesiology 2011; 115:334-343
51. Waterhouse R: A case of suprarenal apoplexy. Lancet 1911; 1: 577-578
52. Sharshar T, Annane D, de la Grandmaison GL, et al: The neuropathology of septic shock. Brain Pathol 2004; 14:21-33
53. Mélik Parsadaniantz S, Levin N, Lenoir V, et al: Human interleukin 1 beta: Corticotropin releasing factor and ACTH release and gene expression in the male rat: In vivo and in vitro studies. J Neurosci Res 1994; 37:675-682
54. Parsadaniantz SM, Batsché E, Gegout-Pottie P, et al: Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. Neuroendocrinology 1997; 65:53-63
55. Wong ML, Rettori V, al-Shekhlee A, et al: Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 1996; 2:581-584
56. Sharshar T, Gray F, Lorin de la Grandmaison G, et al: Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003; 362:1799-1805
57. Polito A, Sonneville R, Guidoux C, et al: Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One 2011; 6:e25905
58. McCann SM, Kimura M, Karanth S, et al: The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann N Y Acad Sci 2000; 917:4-18
59. Boonen E, Langouche L, Janssens T, et al: Impact of duration of critical illness on the adrenal glands of human intensive care patients. J Clin Endocrinol Metab 2014; 99:1569-1582
60. Bornstein SR: Predisposing factors for adrenal insufficiency. N Engl J Med 2009; 360:2328-2339
61. Vuong C, Van Uum SH, O'Dell LE, et al: The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010; 31:98-132
62. Henzen C, Suter A, Lerch E, et al: Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000; 355:542-545
63. Cortés-Puch I, Hicks CW, Sun J, et al: Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia. Am J Physiol Endocrinol Metab 2014; 307:E994-E1008
64. Annane D, Maxime V, Ibrahim F, et al: Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326
65. Vermes I, Beishuizen A, Hampsink RM, et al: Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80:1238-1242
66. Polito A, Lorin de la Grandmaison G, Mansart A, et al: Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals. Intensive Care Med 2010; 36:1852-1858
67. Buss NA, Gavins FN, Cover PO, et al: Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex. FASEB J 2015; 29:2930-2942
68. Wang N, Weng W, Breslow JL, et al: Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 1996; 271:21001-21004
69. Cai L, Ji A, de Beer FC, et al: SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008; 118:364-375
70. Gilibert S, Galle-Treger L, Moreau M, et al: Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice. J Immunol 2014; 193(2):817-826
71. Bruder EA, Ball IM, Ridi S, et al: Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev 2015; 1:CD010225
72. Daniell HW: Opioid contribution to decreased cortisol levels in critical care patients. Arch Surg 2008; 143:1147-1148
73. Thomson I, Fraser R, Kenyon CJ: Regulation of adrenocortical steroidogenesis by benzodiazepines. J Steroid Biochem Mol Biol 1995; 53:75-79
74. Tominaga T, Fukata J, Naito Y, et al: Effects of corticostatin-I on rat adrenal cells in vitro. J Endocrinol 1990; 125:287-292
75. Dendoncker K, Libert C: Glucocorticoid resistance as a major drive in sepsis pathology. Cytokine Growth Factor Rev 2017; 35:85-96
76. Marik PE: Critical illness-related corticosteroid insufficiency. Chest 2009; 135:181-193
77. Bergquist M, Nurkkala M, Rylander C, et al: Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis. J Infect 2013; 67:574-583
78. Bergquist M, Lindholm C, Strinnholm M, et al: Impairment of neutrophilic glucocorticoid receptor function in patients treated with steroids for septic shock. Intensive Care Med Exp 2015; 3:59
79. Vardas K, Ilia S, Sertedaki A, et al: Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality. Intensive Care Med Exp 2017; 5:10
80. Guerrero J, Gatica HA, Rodríguez M, et al: Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: A prospective cohort study and in vitro experimental assay. Crit Care 2013; 17:R107
81. Meduri GU, Tolley EA, Chrousos GP, et al: Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: Evidence for inadequate endogenous glucocorticoid secretion and inflammationinduced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165:983-991
82. van den Akker EL, Koper JW, Joosten K, et al: Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis. Intensive Care Med 2009; 35:1247-1254
83. Ledderose C, Möhnle P, Limbeck E, et al: Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-α. Crit Care Med 2012; 40:2745-2753
84. Kamiyama K, Matsuda N, Yamamoto S, et al: Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone. Am J Physiol Lung Cell Mol Physiol 2008; 295:L998-L1006
85. Cohen J, Pretorius CJ, Ungerer JP, et al: Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease Severity. Crit Care Med 2016; 44:1034-1041